Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors

Published:2020-05-30 Issue:7 Volume:99 Page:1525-1530
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Mulas Olga,Caocci Giovanni^ORCID,Stagno Fabio,Bonifacio Massimiliano,Annunziata Mario,Luciano Luigiana,Orlandi Ester Maria,Abruzzese Elisabetta,Sgherza Nicola,Martino Bruno,Albano Francesco,Galimberti Sara,Pregno Patrizia,Bocchia Monica,Castagnetti Fausto,Tiribelli Mario,Binotto Gianni,Gozzini Antonella,Capodanno Isabella,Fozza Claudio,Luzi Debora,Efficace Fabio,Simula Maria Pina,Scaffidi Luigi,De Gregorio Fiorenza,Elena Chiara,Trawinska Malgorzata Monika,Cattaneo Daniele,Attolico Imma,Baratè Claudia,Pirillo Francesca,Sicuranza Anna,Gugliotta Gabriele,Stella Rossella,Scalzulli Emilia,Iurlo Alessandra,Foà Robin,Breccia Massimo,La Nasa Giorgio

Funder

Regione Autonoma della Sardegna

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04102-6.pdf

Reference21 articles.

1. Sasaki K, Strom SS, O’Brien S, Jabbour E, Ravandi F, Konopleva M et al (2015) Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol 2(5):e186–e193

2. Caocci G, Mulas O, Annunziata M, Luciano L, Abruzzese E, Bonifacio M et al (2020) Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors. Int J Cardiol 301:163–166

3. Caocci G, Atzeni S, Orrù N, Azzena L, Martorana L, Littera R, Ledda A, la Nasa G (2008) Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia. 22(11):2127–2128